On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Nanoplatforms for cancer theranostics

TopicLeading institutions, researchers & key papers

Nanoplatforms for cancer theranostics is a topic indexed in ScholarIQ from OpenAlex.

What is known about Nanoplatforms for cancer theranostics?

ScholarIQrecord summary

This cluster of papers explores the use of nanotechnology, reactive oxygen species, and advanced imaging techniques for targeted cancer therapy and diagnosis. It covers a wide range of topics including photothermal therapy, fluorescence imaging, nanoparticle-based drug delivery, and the development of theranostic agents for combined imaging and therapy. The research also delves into the potential of immunotherapy and the use of biomimetic nanoparticles for enhanced cancer treatment.

How many works does Nanoplatforms for cancer theranostics have?

ScholarIQindexed works

Nanoplatforms for cancer theranostics has 306 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Nanoplatforms for cancer theranostics?

ScholarIQopenalex

The OpenAlex for Nanoplatforms for cancer theranostics is on the source record.

What are the most-cited papers on Nanoplatforms for cancer theranostics?

ScholarIQmost cited works
Light‐Triggered Theranostics Based on Photosensitizer‐Conjugated Carbon Dots for Simultaneous Enhanced‐Fluorescence Imaging and Photodynamic Therapy
Peng Huang, Jing Lin, Xiansong Wang, Zhe Wang, Chunlei Zhang, He Meng, Kan Wang, Feng Chen, Zhiming Li, Guangxia Shen, Daxiang Cui, Xiaoyuan Chen
Advanced Materials. 2012697 Citations
Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer
Jun Xu, Ligeng Xu, Chenya Wang, Rong Yang, Qi Zhuang, Xiao Han, Ziliang Dong, Wenwen Zhu, Rui Peng, Zhuang Liu
ACS Nano. 2017697 Citations
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Qian Chen, Jiawen Chen, Zhijuan Yang, Jun Xu, Ligeng Xu, Chao Liang, Xiao Han, Zhuang Liu
Advanced Materials. 2019680 Citations
Biomedical Applications of Zinc Oxide Nanomaterials
Yi Zhang, Tapas R. Nayak, Hao Hong, Weibo Cai
Current Molecular Medicine. 2013653 CitationsOPEN ACCESS
Plasmonic Copper Sulfide Nanocrystals Exhibiting Near-Infrared Photothermal and Photodynamic Therapeutic Effects
Shunhao Wang, Andreas Riedinger, Hongbo Li, Changhui Fu, Huiyu Liu, Linlin Li, Tianlong Liu, Longfei Tan, Markus J. Barthel, Giammarino Pugliese, Francesco De Donato, Marco Scotto d’Abbusco, Xianwei Meng, Liberato Manna, Huan Meng, Teresa Pellegrino
ACS Nano. 2015610 Citations

Where is Nanoplatforms for cancer theranostics research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Nanoplatforms for cancer theranostics is open access?

ScholarIQopen access share
27%OPEN ACCESS
Gold
20%
Green
7%
Hybrid
0%
Bronze
0%
Closed
73%

Related on ScholarIQ

470M+ articles · 14-day free trial